Sarah Kathryn Rouan Navidea Biopharmaceuticals, Inc. (NAVB) insider trading activity
Sarah Kathryn Rouan is Director of NAVIDEA BIOPHARMACEUTICALS, INC.. Currently has a direct ownership of 18,242 shares of NAVB, which is worth approximately $0. The most recent transaction as insider was on Jun 30, 2021, when has been sold 4,892 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).
Shares Held (Direct Ownership)
18.2K
0%
3M change
0%
12M change
Total Value Held
$0
Sarah Kathryn Rouan Transaction History
Also insider at
SKR
Sarah Kathryn Rouan
Director
San Diego, CA